Authors:
LANATA CF
MIDTHUN K
BLACK RE
BUTRON B
HUAPAYA A
PENNY ME
VENTURA G
GIL A
JETTGOHEEN M
DAVIDSON BL
Citation: Cf. Lanata et al., SAFETY, IMMUNOGENICITY, AND PROTECTIVE EFFICACY OF ONE AND 3 DOSES OFTHE TETRAVALENT RHESUS ROTAVIRUS VACCINE IN INFANTS IN LIMA, PERU, The Journal of infectious diseases, 174(2), 1996, pp. 268-275
Citation: Ls. Henchal et al., SELECTED REGULATORY AND SCIENTIFIC TOPICS FOR CANDIDATE ROTAVIRUS VACCINE DEVELOPMENT, The Journal of infectious diseases, 174, 1996, pp. 112-117
Authors:
CEYHAN M
KANRA G
SECMEER G
MIDTHUN K
DAVIDSON BL
ZITO ET
VESIKARI T
Citation: M. Ceyhan et al., TAKE OF RHESUS-HUMAN REASSORTANT TETRAVALENT ROTAVIRUS VACCINE IN BREAST-FED INFANTS, Acta paediatrica, 82(3), 1993, pp. 223-227